“Formulation Design and Development of Anti-EGFR-BSA-CYP-SLNs In Situ Gel for Nasal Administration”. Asian Journal of Pharmaceutics (AJP), vol. 10, no. 04, Dec. 2016, https://doi.org/10.22377/ajp.v10i04.927.